Treatment Information

Back

Liver Cancer treatment details. Hormone.

Universitaire Amiens Nord, Amiens Cedex, France.

Survival: monthsCountry:France
Toxiciy Grade:5City/State/Province:Amiens Cedex
Treatments:HormoneHospital:Universitaire Amiens Nord
Drugs:Journal:Link
Date:Jul 2009

Description:

Patients:
This phase 3 study involved 135 advanced hepatocellular carcinoma patients. The average patient age was 65 years and 81% were male.

Treatment:
Patients were treated with the hormone drug called octreotide, which is similar to the biological hormone somatostatin and may interfere with cancer cell growth signals.

Toxicities:
There was one treatment-related death due to stroke in this study. Grade 3/4 diarrhea was also reported.

Results:
The median overall survival was 6.53 months.

Support:
This study was supported by Novartis Pharma.

Correspondence: Dr. Jean Claude Barbare; email: [email protected]



Back